INTERPRETATION OF SPIROMETRIC PARAMETERS OF PATIENTS WITH NORMAL RESPIRATORY FUNCTION of
bronchodilation tests are studied depending on the initial spirometric parameters.The article talks about the need
Pharmacoeconomic assessment of dual bronchodilation therapy in patients with COPD-acting
bronchodilators (LABD) to glycopyrronium bromide/indacaterol fixed combination has led to 20.44% decrease
Inhaled therapies in patients with moderate COPD in clinical practice: Current thinking, how physical activity can improve disease outcomes, the benefits of dual
bronchodilation in COPD
Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day studyThe safety and tolerability of indacaterol, a novel once-daily β -agonist
bronchodilator with a